Physician profile
Jonathan D Meek
NPI 1366416380
$1,322.40
in general payments reported to CMS, 2019-2025
19 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $951 · 2024: $172 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $282.55 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.62 | 2019 | |
| Pfizer INC. | $153.20 | 2019 | |
| Abbott Laboratories | $125.03 | 2019-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $110.36 | 2019 | |
| Lilly USA, LLC | $71.57 | 2024-2025 | Zepbound, Mounjaro |
| Amgen INC. | $58.60 | 2019 | |
| Sanofi-Aventis U.S. LLC | $45.03 | 2019 | |
| Boston Scientific Corporation | $44.37 | 2019-2025 | Axonics |
| Exact Sciences Corporation | $29.28 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $27.60 | 2019 | |
| Abbvie INC. | $20.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.92 | 2019 | |
| Sanofi Pasteur INC. | $14.27 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.63 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $12.33 | 2019 | |
| Shire North American Group INC | $11.53 | 2019 | |
| Merck Sharp & Dohme LLC | $11.06 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Meek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.